ANDA 40504, held by Able. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40504 (Promethazine Hydrochloride), held by Able, was first approved by FDA on Apr 11, 2003, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 11, 2003 | Original application | Approved | None posted |
| Promethazine Hydrochloride12.5MG · suppository;rectal | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride25MG · suppository;rectal | Promethazine Hydrochloride | Discontinued |
| Jun 21, 2005 | Supplement 4Labeling | Approved | None posted |
| Apr 20, 2004 | Supplement 1Labeling | Approved | None posted |
| Apr 11, 2003 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters